Trial
NCT03032614
Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
—
Condition
Breast Cancer Stage IV
Intervention
Carboplatin
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-10